SCHEMBL649873

SCHEMBL649873

CCCCOC(=O)C(C)(C)Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
ATM Q13315 1/20 0.48
TSHR P16473 5/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HPGD P15428 1/20 0.45
ESR1 P03372 7/20 0.43
LMNA P02545 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
MAPK1 P28482 2/20 0.43
CYP2D6 P10635 1/20 0.43
NR1H2 P55055 1/20 0.43
RNASEL Q05823 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
NAAA Q02083 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 1/20 0.42
PDE4D Q08499 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11457160 0.94 NAAA (0.50) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL652686 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL652601 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL3645547 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL18018655 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL19865613 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL650595 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL649600 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL28919926 0.92 NAAA (0.53) ALDH1A1TSHRESR1LMNAMAPK1
SCHEMBL37083 0.89 POLB (0.39) ALDH1A1TSHRTDP1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106833251-B fluorine-free super-hydrophobic coating and preparation method thereof 常州大学 2019-12-06 CN claimed
US-12265356-B2 Photoresponsive polymer, photoresponsive adhesive, toner, and image forming method Konica Minolta, Inc. (JP) 2025-04-01 US disclosed
US-12181833-B2 Photoresponsive polymer Konica Minolta, Inc. (JP) 2024-12-31 US disclosed
EP-3696200-B1 PHOTORESPONSIVE HIGH-MOLECULAR WEIGHT MATERIAL, ADHESIVE, TONER, AND IMAGE FORMING METHOD KONICA MINOLTA INC (JP) 2024-08-28 EP disclosed
US-12037531-B2 Photoresponsive high-molecular weight material, adhesive, toner, and image forming method Konica Minolta, Inc. (JP) 2024-07-16 US disclosed
US-12025909-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-07-02 US disclosed
US-11994827-B2 Photoresponsive polymer Konica Minolta, Inc. (JP) 2024-05-28 US disclosed
US-11976230-B2 Photoresponsive material, adhesive, optical switching material, toner, and image forming method Konica Minolta, Inc. (JP) 2024-05-07 US disclosed
CN-113552782-B Light responsive material, adhesive, light switching material, toner and image forming method 柯尼卡美能达株式会社 2024-02-02 CN disclosed
CN-115806401-B Preparation method of water reducer special for tailing sand containing multiple adsorption groups 江苏博思通新材料有限公司 2024-01-12 CN disclosed
US-6699904-B2 PEROXISOME PROLIFERATOR ACTIVATOR RECEPTOR (PPAR) AGONISTS; ATHEROSCLEROSIS AND CARDIOVASCULAR DISORDERS; FOR EXAMPLE, 3-(4-(2-(3-(2,4-DIMETHOXY-PHENYL)-1-HEPTYL-UREIDO)-ETHYL)-PHENYL)-2-ETHOXY -PROPIONIC ACID PFIZER INC. 2004-03-02 US disclosed
EP-1372632-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS Pfizer Products Inc. (US) 2004-01-02 EP disclosed
EP-1360172-A1 PPAR AGONISTS Pfizer Products Inc. (US) 2003-11-12 EP disclosed
US-20020169192-A1 PPAR compounds HAYWARD CHERYL M (US) 2002-11-14 US disclosed
US-20020165282-A1 Peroxisome proliferator activator receptor (PPAR) agonists; atherosclerosis and cardiovascular disorders; for example, 3-(4-(2-(3-(2,4-dimethoxy-phenyl)-1-heptyl-ureido)-ethyl)-phenyl)-2-ethoxy -propionic acid HAYWARD CHERYL M (US) 2002-11-07 US disclosed
WO-2002064549-A1 PPAR AGONISTS PFIZER PRODUCTS INC. (US) 2002-08-22 WO disclosed
WO-2002064130-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS PFIZER PRODUCTS INC. (US) 2002-08-22 WO disclosed
EP-0015523-B1 INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR MEDICAMENTS Dr. Karl Thomae GmbH (DE) 1982-10-13 EP disclosed
EP-0015523-A1 Indole derivatives, their preparation and their use for medicaments Dr. Karl Thomae GmbH (DE) 1980-09-17 EP disclosed
US-4010279-A BIPHENYLOXY DERIVATIVES AND ANTIHYPERLIPIDEMIC USE BOEHRINGER INGELHEIM GMBH (DT) 1977-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165282-A1 Peroxisome proliferator activator receptor (PPAR) agonists; atherosclerosis and cardiovascular disorders; for example, 3-(4-(2-(3-(2,4-dimethoxy-phenyl)-1-heptyl-ureido)-ethyl)-phenyl)-2-ethoxy -propionic acid PPARA, PPARG, PPARD ALDH1A1 1183/4885ATM 1963/4885TSHR 356/4885
US-20020169192-A1 PPAR compounds PPARA, PPARG, PPARD ALDH1A1 1922/4885ATM 807/4885TSHR 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.